$ELV

3 theses
bullish 33%neutral 0%bearish 67%
Avg return (1w)
-1.8%
Win rate (1w)
50% (2 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Nov 20, 4:50 PM ET
$ELVSEC Form 4bullish$394.48
no track record yet8h ago
Long 1,000 shares of ELV
Bought 1,000 @ $383.86 avg · $383,860 · 2026-11-19

Form 4: PERU RAMIRO G bought ELV

PERU RAMIRO G (Director at Elevance Health, Inc.) reported an open-market purchase of 1,000 shares of ELV at an average $383.86, roughly $383,860, in a Form 4 filed 2026-11-20.

ELV $400.00 C · Dec 18
Finishes above $400.00 in 28 days
49%
View filing on SEC.gov →
$ELVSEC Form 4bearish$394.48from $425.62 at post-7.3%
no track record yet14d ago
Sold 1,300 @ $440.00 avg · $572,000 · 2026-11-05

Form 4: LAVU RATNAKAR sold ELV

LAVU RATNAKAR (EVP & Chief Digital Info Ofr at Elevance Health, Inc.) reported an open-market sale of 1,300 shares of ELV at an average $440.00, roughly $572,000, in a Form 4 filed 2026-11-06.

1d—
3d-1.7%
1w+1.0%
1m—
3m—
6m—
1y—
ELV $440.00 P · Dec 18
Finishes below $440.00 in 28 days
76%
▼ 5.9%
View filing on SEC.gov →
$ELVSEC Form 4bearish$394.48from $439.95 at post-10.3%
no track record yet28d ago
Sold 10,584 @ $440.13 avg · $4,658,357 · 2026-10-22

Form 4: Kaye Mark sold ELV

Kaye Mark (EVP & CFO at Elevance Health, Inc.) reported an open-market sale of 10,584 shares of ELV at an average $440.13, roughly $4,658,357, in a Form 4 filed 2026-10-23.

1d—
3d-2.0%
1w-4.5%
1m—
3m—
6m—
1y—
ELV $450.00 P · Dec 18
Finishes below $450.00 in 28 days
80%
▼ 2.4%
View filing on SEC.gov →

End of results.